Fusion inhibition--a major but costly step forward in the treatment of HIV-1
- PMID: 12773653
- DOI: 10.1056/NEJMe030042
Fusion inhibition--a major but costly step forward in the treatment of HIV-1
Comment on
-
Enfuvirtide, an HIV-1 fusion inhibitor, for drug-resistant HIV infection in North and South America.N Engl J Med. 2003 May 29;348(22):2175-85. doi: 10.1056/NEJMoa035026. Epub 2003 Mar 13. N Engl J Med. 2003. PMID: 12637625 Clinical Trial.
-
Efficacy of enfuvirtide in patients infected with drug-resistant HIV-1 in Europe and Australia.N Engl J Med. 2003 May 29;348(22):2186-95. doi: 10.1056/NEJMoa035211. N Engl J Med. 2003. PMID: 12773645 Clinical Trial.
Similar articles
-
HIV infection--a new drug and new costs.N Engl J Med. 2003 May 29;348(22):2171-2. doi: 10.1056/NEJMp030043. N Engl J Med. 2003. PMID: 12773643 No abstract available.
-
Fuzeon treatment forum, January 2004.Surviv News (Atlanta Ga). 2004 Jan-Feb;15(1):10. Surviv News (Atlanta Ga). 2004. PMID: 15032144 No abstract available.
-
Clinical trials for enfuvirtide (Fuzeon, T-20).AIDS. 2003 Nov 21;17(17):N13-4. AIDS. 2003. PMID: 15065580 No abstract available.
-
[Enfuvirtide, mechanism of action and pharmacological properties].Med Arh. 2005;59(5):313-6. Med Arh. 2005. PMID: 16134757 Review. Bosnian.
-
Enfuvirtide.Drugs Today (Barc). 2004 Mar;40(3):259-69. doi: 10.1358/dot.2004.40.3.820089. Drugs Today (Barc). 2004. PMID: 15148534 Review.
Cited by
-
Cost-efficacy comparison among three antiretroviral regimens in HIV-1 infected, treatment-experienced patients.Clin Drug Investig. 2007;27(7):469-79. doi: 10.2165/00044011-200727070-00004. Clin Drug Investig. 2007. PMID: 17563127 Clinical Trial.
-
The potent human immunodeficiency virus type 1 (HIV-1) entry inhibitor HR212 blocks formation of the envelope glycoprotein gp41 six-helix bundle.AIDS Res Hum Retroviruses. 2013 Mar;29(3):613-20. doi: 10.1089/aid.2012.0059. Epub 2013 Jan 11. AIDS Res Hum Retroviruses. 2013. PMID: 23308369 Free PMC article.
-
Resistance of human immunodeficiency virus type 1 to the high-mannose binding agents cyanovirin N and concanavalin A.J Virol. 2005 Jun;79(12):7777-84. doi: 10.1128/JVI.79.12.7777-7784.2005. J Virol. 2005. PMID: 15919930 Free PMC article.
-
Cost-Effectiveness of Antiretroviral Therapy for Multidrug-Resistant HIV: Past, Present, and Future.AIDS Res Treat. 2012;2012:595762. doi: 10.1155/2012/595762. Epub 2012 Nov 8. AIDS Res Treat. 2012. PMID: 23193464 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical